Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / SHS
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
14,291,722
-
Shares change
-
-730,676
-
Total reported value, excl. options
-
$57,166,356
-
Value change
-
-$3,455,706
-
Put/Call ratio
-
48%
-
Number of buys
-
12
-
Number of sells
-
22
-
Price
-
$4.00
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q1 2022
As of 31 Mar 2022 AC Immune SA - SHS (ACIU) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,291,722 shares of stock of the company.
Largest 10 holders included BVF INC/IL, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, Artal Group S.A., WELLS FARGO & COMPANY/MN, EcoR1 Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DEUTSCHE BANK AG\, and Assenagon Asset Management S.A..
This table shows 52 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.